Multiview boosting digital pathology analysis of prostate cancer

In 2016, it is expected that more than 180,000 men are diagnosed with prostate cancer and more than 26,000 men are died from the disease (second leading cause of deaths from cancer) [1]. For prostate cancer diagnosis, over one million biopsies are annually performed. Biopsied prostate specimens are sectioned and usually stained with hematoxylin and eosin (H&E) to enhance the contrast in specimens. The stained specimens are examined under an optical brightfield microscopy by pathologists. A majority of the specimens are negative for prostate cancer.
Source: Computer Methods and Programs in Biomedicine - Category: Bioinformatics Authors: Source Type: research